MDxHealth SA (STU:O6C1)
€ 2.98 0 (0%) Market Cap: 81.15 Mil Enterprise Value: 88.51 Mil PE Ratio: 0 PB Ratio: 5.52 GF Score: 16/100

Full Year 2022 MDxHealth SA Earnings Call Transcript

Mar 08, 2023 / 09:30PM GMT
Release Date Price: €3.48 (+9.95%)
Operator

Greetings. Welcome to the MDxHealth fourth quarter and full-year 2022 earnings call. (Operator Instructions) Please note this conference is being recorded.

Before we begin, I would like to remind everyone that we will make forward-looking statements during today's call, whether in prepared remarks or during the Q&A session. These forward-looking statements are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the risk factors section of our filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 20-F.

I will now turn the conference over to your host, Michael McGarrity, Chief Executive Officer. You may begin.

Michael McGarrity
MDxHealth SA - CEO

Thanks, Shomali. Thank you all for joining us for our 2022 full-year release of results for MDxHealth. With me today is Ron Kalfus, Chief Financial Officer.

As you are likely aware, prostate cancer is the most common form of cancer in men. When I joined MDxHealth in 2019, my vision was to continue

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot